Congratulations to George Tofaris, IMPRiND coordinator, who has been awarded a prestigious MRC Senior Clinical Fellowship. He is using induced pluripotent stem cells (iPSC) derived from patients to model alpha-synuclein aggregation in human neurons, and genetic screens to decipher relevant pathways that target aggregated alpha-synuclein for destruction. This MRC Fellowship will allow George's team to continue their work on fundamental mechanisms that cause Parkinson's disease @The_MRC. This is also an example of how IMI funding promotes academic careers and further collaborations @imprind
This project receives funding from the Innovative Medicines Initiative 2 Joint Undertaking (www.imi.europa.eu) under grant agreement No 116060. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
This work is supported by the Swiss State Secretariat for Education‚ Research and Innovation (SERI) under contract number 17.00038.
The opinions expressed and arguments employed herein do not necessarily reflect the official views of these funding bodies.